(Q36651656)

15 August 2017

1 reference

title

Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy (English)

1 reference

15 August 2017

anti-retroviral agent

0 references

1 reference

Bente Magny Bergersen

series ordinal

1

1 reference

15 August 2017

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

66

1 reference

15 August 2017

1971-1987

1 reference

15 August 2017

15

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200666150-00006

15 August 2017

0 references

cites work

Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome

1 reference

12 December 2020

Emtricitabine: a novel nucleoside reverse transcriptase inhibitor

1 reference

12 December 2020

Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome

1 reference

12 December 2020

HLA-B*5701 typing by sequence-specific amplification: validation and comparison with sequence-based typing

1 reference

12 December 2020

Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.

1 reference

12 December 2020

Modifiable dietary habits and their relation to metabolic abnormalities in men and women with human immunodeficiency virus infection and fat redistribution

1 reference

12 December 2020

Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection

1 reference

12 December 2020

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

12 December 2020

Premature atherosclerosis in HIV-infected individuals--focus on protease inhibitor therapy

1 reference

12 December 2020

Human immunodeficiency virus type-1 accessory protein Vpr: a causative agent of the AIDS-related insulin resistance/lipodystrophy syndrome?

1 reference

12 December 2020

Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS

1 reference

12 December 2020

Coronary heart disease in HIV-infected individuals

1 reference

12 December 2020

Short-term exercise training improves body composition and hyperlipidaemia in HIV-positive individuals with lipodystrophy

1 reference

12 December 2020

Insulin resistance in the HIV-lipodystrophy syndrome

1 reference

12 December 2020

Premature atherosclerosis in HIV positive patients and cumulated time of exposure to antiretroviral therapy (SHIVA study).

1 reference

12 December 2020

1 reference

12 December 2020

Prevalence of metabolic syndrome among HIV patients

1 reference

12 December 2020

Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls.

1 reference

12 December 2020

Chronic infections and coronary heart disease: is there a link?

1 reference

12 December 2020

Psoas muscle attenuation measurement with computed tomography indicates intramuscular fat accumulation in patients with the HIV-lipodystrophy syndrome

1 reference

12 December 2020

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

1 reference

12 December 2020

A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia

1 reference

12 December 2020

Tumour necrosis factor-alpha gene -238G/A promoter polymorphism associated with a more rapid onset of lipodystrophy

1 reference

12 December 2020

Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile

1 reference

12 December 2020

Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance

1 reference

12 December 2020

Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitors.

1 reference

12 December 2020

Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia

1 reference

12 December 2020

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

1 reference

12 December 2020

96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures

1 reference

12 December 2020

Abnormal levels of circulating adhesion molecules in HIV-1 infection with characteristic alterations in opportunistic infections

1 reference

12 December 2020

Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study

1 reference

12 December 2020

Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine

1 reference

12 December 2020

Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America

1 reference

12 December 2020

Dietary influences on serum lipids and lipoproteins

1 reference

12 December 2020

SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients

1 reference

12 December 2020

Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition

1 reference

12 December 2020

Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study

1 reference

12 December 2020

Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects

1 reference

12 December 2020

Association of hypocholesterolaemia with hepatitis C virus infection in HIV-infected people.

1 reference

12 December 2020

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study

1 reference

12 December 2020

Colour-Doppler ultrasonography of carotid vessels in patients treated with antiretroviral therapy: a comparative study.

1 reference

12 December 2020

Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection.

1 reference

12 December 2020

Cardiovascular disease risk profiles.

1 reference

12 December 2020

Serum lipid profile of patients with genotype 1b hepatitis C viral infection in Japan

1 reference

12 December 2020

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

1 reference

12 December 2020

The effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adults

1 reference

12 December 2020

Recreational drug misuse: issues for the cardiologist

1 reference

12 December 2020

An open-label, prospective, observational study of the incidence of coronary artery disease in patients with hiv infection receiving highly active antiretroviral therapy

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes.

1 reference

12 December 2020

Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities

1 reference

12 December 2020

Indinavir and systemic hypertension

1 reference

12 December 2020

Rosiglitazone in the treatment of HAART-associated lipodystrophy--a randomized double-blind placebo-controlled study.

1 reference

12 December 2020

Cardio- and cerebrovascular events in HIV-infected persons.

1 reference

12 December 2020

Insulin resistance in HIV-infected patients: relationship with pro-inflammatory cytokines released by peripheral leukocytes

1 reference

12 December 2020

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

1 reference

12 December 2020

Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.

1 reference

12 December 2020

Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study

1 reference

12 December 2020

Nelfinavir and felodipine: a cytochrome P450 3A4-mediated drug interaction

1 reference

12 December 2020

A pilot study of exercise training to reduce trunk fat in adults with HIV-associated fat redistribution

1 reference

12 December 2020

Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers

1 reference

12 December 2020

Prediction of creatinine clearance from serum creatinine

1 reference

12 December 2020

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

1 reference

12 December 2020

Absence of age-related increase in systolic blood pressure in ambulatory patients with HIV infection

1 reference

12 December 2020

Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects

1 reference

12 December 2020

Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors

1 reference

12 December 2020

Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.

1 reference

12 December 2020

Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate

1 reference

12 December 2020

Toxicity of non-nucleoside analogue reverse transcriptase inhibitors

1 reference

12 December 2020

Tipranavir: a ritonavir-boosted protease inhibitor.

1 reference

12 December 2020

Predictors of hypertension and changes of blood pressure in HIV-infected patients.

1 reference

12 December 2020

Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA.

1 reference

12 December 2020

Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients

1 reference

12 December 2020

Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?

1 reference

12 December 2020

Insulin resistance status is an important determinant of PAI-1 levels in HIV-infected patients, independently of the lipid profile.

1 reference

12 December 2020

Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin

1 reference

12 December 2020

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

1 reference

12 December 2020

Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir

1 reference

12 December 2020

Differentiating hyperlipidaemia associated with antiretroviral therapy

1 reference

12 December 2020

Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial

1 reference

12 December 2020

Elevated blood pressure in subjects with lipodystrophy

1 reference

12 December 2020

Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of 'systemic steatosis'.

1 reference

12 December 2020

No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Combination antiretroviral therapy and the risk of myocardial infarction

1 reference

12 December 2020

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

1 reference

12 December 2020

Emtricitabine, a new antiretroviral agent with activity against HIV and hepatitis B virus

1 reference

12 December 2020

Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations

1 reference

12 December 2020

Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients

1 reference

12 December 2020

The effects of HIV infection on endothelial function

1 reference

12 December 2020

1 reference

12 December 2020

Dietary advice with or without pravastatin for the management of hypercholesterolaemia associated with protease inhibitor therapy

1 reference

12 December 2020

Impact of HIV infection and HAART on serum lipids in men.

1 reference

12 December 2020

Successful cardiac transplantation in an HIV-1-infected patient with advanced disease

1 reference

12 December 2020

A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study

1 reference

12 December 2020

Hypertension in HIV-1-infected patients and its impact on renal and cardiovascular integrity

1 reference

12 December 2020

Alcohol consumption is associated with enrichment of high-density lipoprotein particles in polyunsaturated lipids and increased cholesterol esterification rate

1 reference

12 December 2020

Alteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome.

1 reference

12 December 2020

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

1 reference

12 December 2020

Electron beam computed tomography for assessment of coronary artery disease in HIV-infected men receiving antiretroviral therapy

1 reference

12 December 2020

Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients

1 reference

12 December 2020

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

1 reference

12 December 2020

The metabolic effects of lopinavir/ritonavir in HIV-negative men

1 reference

12 December 2020

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the

1 reference

12 December 2020

Low prevalence of high-density lipoprotein cholesterol level < 1 mmol/L in non-nucleoside reverse transcriptase inhibitor recipients

1 reference

12 December 2020

Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy.

1 reference

12 December 2020

Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy

1 reference

12 December 2020

Hypertension in the HIV-infected patient

1 reference

12 December 2020

Metabolic effects of indinavir in healthy HIV-seronegative men

1 reference

12 December 2020

10.2165/00003495-200666150-00006

Identifiers

DOI

1 reference

PubMed ID

17100407

Dimensions Publication ID

15 August 2017

0 references

1 reference

PubMed ID

17100407